133 related articles for article (PubMed ID: 38078203)
21. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
[TBL] [Abstract][Full Text] [Related]
22. Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
Khunger M; Rakshit S; Hernandez AV; Pasupuleti V; Glass K; Galsky MD; Grivas P
Oncologist; 2018 Dec; 23(12):1494-1499. PubMed ID: 30068783
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trials in neurosurgery: an observational analysis of trial discontinuation and publication outcome.
Jamjoom AAB; Gane AB; Demetriades AK
J Neurosurg; 2017 Oct; 127(4):857-866. PubMed ID: 27885950
[TBL] [Abstract][Full Text] [Related]
24. The use of telecommunication and virtualization among ongoing and discontinued COVID-19 clinical trials: A cross-sectional analysis.
Greenough MC; Sajjadi NB; Rucker B; Vassar M; Hartwell M
Contemp Clin Trials; 2022 Mar; 114():106681. PubMed ID: 35045363
[TBL] [Abstract][Full Text] [Related]
25. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
26. Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov.
Sakamaki K; Uemura Y; Shimizu Y
Trials; 2021 Nov; 22(1):788. PubMed ID: 34749761
[TBL] [Abstract][Full Text] [Related]
27. Early Termination of Oncology Clinical Trials in the United States.
Zhang E; DuBois SG
Cancer Med; 2023 Mar; 12(5):5517-5525. PubMed ID: 36305832
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
Varshney AS; Wang DE; Bhatt AS; Blood A; Sharkawi MA; Siddiqi HK; Vaduganathan M; Monteleone PP; Patel MR; Jones WS; Lopes RD; Mehra MR; Bhatt DL; Kochar A
Am Heart J; 2021 Feb; 232():105-115. PubMed ID: 33121978
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 pandemic response varies by clinical trial sponsor type.
Cooper L; Lee I; Waldron Lechner D
J Clin Transl Sci; 2021 Mar; 5(1):e111. PubMed ID: 34192064
[TBL] [Abstract][Full Text] [Related]
30. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
31. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.
Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M
J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
33. Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
Rodgers F; Pepperrell T; Keestra S; Pilkington V
Trials; 2021 Jan; 22(1):59. PubMed ID: 33451350
[TBL] [Abstract][Full Text] [Related]
34. Indications of Recruitment Challenges in Research with U.S. Military Service Members: A ClinicalTrials.gov Review.
Cook WA; Doorenbos AZ
Mil Med; 2017 Mar; 182(3):e1580-e1587. PubMed ID: 28290928
[TBL] [Abstract][Full Text] [Related]
35. Analysis of factors leading to early termination in glioblastoma-related clinical trials.
Shah HA; Mishra A; Gouzoulis MJ; Ben-Shalom N; D'Amico RS
J Neurooncol; 2022 Jul; 158(3):489-495. PubMed ID: 35648307
[TBL] [Abstract][Full Text] [Related]
36. The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov.
Sacks CA; North CM; Wolf M; Dougan M; Campbell KR; Moggridge J; Fralick M
J Gen Intern Med; 2022 Jan; 37(1):154-161. PubMed ID: 34755268
[TBL] [Abstract][Full Text] [Related]
37. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
38. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
39. General characteristics and reasons for the discontinuation of drug clinical trials in mainland China.
Huo BN; Ai ML; Jia YT; Liu Y; Wang Y; Yin NG; Song L
BMC Med Res Methodol; 2021 Nov; 21(1):246. PubMed ID: 34773983
[TBL] [Abstract][Full Text] [Related]
40. The impact of COVID-19 on autism research: A cross-sectional analysis of discontinued or suspended clinical trials.
Neale M; Landers E; Sajjadi NB; Mazur-Mosiewicz A; Hartwell M
Autism Res; 2022 Aug; 15(8):1560-1564. PubMed ID: 35670304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]